Regulation of receptor tyrosine kinase signaling by GRKs and β-arrestins

Annual Review of Physiology

Volumn 69, Issue , 2007, Pages 561-577

  Hupfeld, Christopher J ^a   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

G proteins; IGF 1; Insulin

Indexed keywords

BETA ARRESTIN; BETA ARRESTIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEASOME; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ENZYME ACTIVITY; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR CROSS-TALK; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 33947354585     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.69.022405.154626     Document Type: Review

References (71)

1. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-25
2. Hubbard SR, Mohammadi M, Schlessinger J. 1998. Autoregulatory mechanisms in protein-tyrosine kinases. J. Biol. Chem. 273:11987-90
3. Lee J, Pilch PF. 1994. The insulin receptor: structure, function, and signaling. Am. J. Physiol. Cell Physiol. 266:C319-34
4. Hubbard SR. 1997. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:5572-81
5. Eck MJ, Dhe-Paganon S, Trub T, Nolte RT, Shoelson SE. 1996. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85:695-705
6. Gustafson T, He W, Craparo A, Schaub C, O'Neill T. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptorvia a novel non- SH2 domain. Mol. Cell Biol. 15:2500-8
7. Bork P, Margolis B. 1995. A phosphotyrosine interaction domain. Cell 80:693-94
8. Virkamaki A, Ueki K, Kahn CR. 1999. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103:931-43
9. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, et al. 2001. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410:944-48
10. α-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol. Cell Biol. 19:6765-74
11. Luttrell LM, van Biesen T, Hawes BE, Koch WJ, Touhara K, Lefkowitz RJ. 1995. Gβγ subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J. Biol. Chem. 270:16495-98
12. Dalle S, Ricketts W, Imamura T, Vollenweider P, Olefsky JM. 2001. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276:15688-95
13. i with the insulin-like growth factor-I receptor. Release of Gβγ subunits upon receptor activation. J. Biol. Chem. 275:2255-58
14. i2 in human intestinal smooth muscle. Gβγ -dependent mitogen-activated protein kinase activation and growth. J. Biol. Chem. 276:7187-94
15. 11) alpha subunit is required for insulin-stimulated GLUT4 translocation in 3T3L1 adipocytes. J. Biol. Chem. 275:7167-75
16. Usui I, Imamura T, Huang J, Satoh H, Olefsky JM. 2003. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 278:13765-74
17. Kishi K, Muromoto N, Nakaya Y, Miyata I, Hagi A, et al. 1998. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 47:550-58
18. o. FEBS Lett. 212:281-88
19. Ciaraldi TP, Maisel A. 1989. Role of guanine nucleotide regulatory proteins in insulin stimulation of glucose transport in rat adipocytes. Influence of bacterial toxins. Biochem. J. 264:389-96
20. Goren HJ, Northup JK, Hollenberg MD. 1985. Action of insulin modulated by pertussis toxin in rat adipocytes. Can. J. Physiol. Pharmacol. 63:1017-22
21. Moreno F, Mills I, Garcia-Sainz J, Fain J. 1983. Effects of pertussis toxin treatment on the metabolism of rat adipocytes. J. Biol. Chem. 258:10938-43
22. αi2 with epidermal growth factor receptor signaling in rat hepatocytes, and the inhibitory effect of chronic ethanol. Biochem. Pharmacol. 61:1021-27
23. Øyvind Melien DS, Ellen JJ, Thoralf C. 2000. Effects of pertussis toxin on extracellular signal-regulated kinase activation in hepatoeytes by hormones and receptor-independent agents: evidence suggesting a stimulatory role of G proteins at a level distal to receptor coupling. J. Cell Physiol. 184:27-36
24. Øyvind Melien GHT, Dagny S, Eva Ø, Thoralf C. 1998. Activation of p42/p44 mitogen-activated protein kinase by angiotensin II, vasopressin, norepinephrine, and prostaglandin F in hepatoeytes is sustained, and like the effect of epidermal growth factor, mediated through pertussis toxin-sensitive mechanisms. J. Cell Physiol. 175:348-58
25. Piiper A, Gebhardt R, Kronenberger B, Giannini CD, Elez R, Zeuzem S. 2000. Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1. Mol. Pharmacol. 58:608-13
26. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, et al. 2000. The β2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multireceptor complex with the epidermal growth factor receptor. J. Biol. Chem. 275:9572-80
27. Waters C, Pyne S, Pyne NJ. 2004. The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin. Cell Dev. Biol. 15:309-23
28. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, et al. 2003. Insights into G protein structure, function, and regulation. Endocr. Rev. 24:765-81
29. Gelb MH, Scholten JD, Sebolt-Leopold JS. 1998. Protein prenylation: from discovery to prospects for cancer treatment. Curr. Opin. Chem. Biol. 2:40-48
30. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, et al. 1992. Role of βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science 28:1264-67
31. Koch W, Inglese J, Stone W, Lefkowitz R. 1993. The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J. Biol. Chem. 268:8256-60
32. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. 1990. Beta-arrestin: a protein that regulates β-adrenergic receptor function. Science 248:1547-50
33. Violin JD, Ren XR, Lefkowitz RJ. 2006. GRK specificity for β-arrestin recruitment to the β2-adrenergic receptor revealed by fluorescence resonance energy transfer. J. Biol. Chem. 281:20577-88
34. Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, et al. 1997. Clathrin-mediated endocytosis of the β-adrenergic receptor is regulated by phosphorylation/ dephosphorylation of β-arrestinl. J. Biol. Chem. 272:31051-57
35. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ. 1996. Role of c-Src tyrosine kinase in G protein-coupled receptor and Gβγ subunit-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 271:19443-50
36. Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y. 1999. Src-mediated tyrosine phosphorylation of dynamin is required for β2-adrenergic receptor internalization and mitogen-activated protein kinase signaling. J. Biol. Chem. 274:1185-8
37. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, et al. 2001. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98:2449-54
38. Luttrell LM, Ferguson SSG, Daaka Y, Miller WE, Maudsley S, et al. 1999. β-arrestin-dependent formation of 2 adrenergic receptor-Src protein kinase complexes. Science 283:655-61
39. αi-coupled receptors. J. Biol. Chem. 280:1016-23
40. Lin FT, Daaka Y, Lefkowitz RJ. 1998. β-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J. Biol. Chem. 273:31640-43
41. Chow JC, Condorelli G, Smith RJ. 1998. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J. Biol. Chem. 273:4672-80
42. Povsic TJ, Kohout TA, Lefkowitz RJ. 2003. β-arrestinl mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J. Biol. Chem. 278:51334-39
43. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-79
44. Weissman AM. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:169-78
45. Girnita L, Girnita A, Larsson O. 2003. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc. Natl. Acad. Sci. USA 100:8247-52
46. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Girnita A, et al. 2005. β-arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J. Biol. Chem. 280:24412-19
47. Zhande R, Mitchell JJ, Wu J, Sun XJ. 2002. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol. Cell Biol. 22:1016-26
48. Rui L, Yuan M, Frantz D, Shoelson S, White MF. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394-98
49. Usui I, Imamura T, Huang J, Satoh H, Shenoy SK, et al. 2004. β-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. Mol. Cell Biol. 24:8929-37
50. Dalle S, Imamura T, Rose DW, Worrall DS, Ugi S, et al. 2002. Insulin induces heterologous desensitization of G protein-coupled receptor and insulin-like growth factor I signaling by downregulating β-arrestin-1. Mol. Cell Biol. 22:6272-85
51. Ceresa BP, Kao AW, Santeler SR, Pessin JE. 1998. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol. Cell Biol. 18:3862-70
52. Kao AW, Ceresa BP, Santeler SR, Pessin JE. 1998. Expression of a dominant interfering dynamin mutant in 3T3L1 adipocytes inhibits GLUT4 endocytosis without affecting insulin signaling. J. Biol. Chem. 273:25450-57
53. Kim J, Ahn S, Guo R, Daaka Y. 2003. Regulation of epidermal growth factor receptor internalization by G protein-coupled receptors. Biochemistiy 42:2887-94
54. Hunton DL, Barnes WG, Kim J, Ren XR, Violin JD, et al. 2005. β-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol. Pharmacol. 67:1229-36
55. Alderton F, Rakhit S, Kong KC, Palmer T, Sambi B, et al. 2001. Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells. J. Biol. Chem. 276:28578-85
56. Hobson JP, Rosenfeldt HM, Barak LS, Olivera A, Poulton S, et al. 2001. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291:1800-3
57. Huang EJ, Reichardt LF. 2001. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24:677-736
58. i/o, G protein-coupled receptor kinase 2, β-arrestin I, and endocytic processing. Mol. Pharmacol. 60:63-70
59. Xu CB, Zhang Y, Stenman E, Edvinsson L. 2002. D-Erythro-N,N-dimethylsphingosine inhibits bFGF-induced proliferation of cerebral, aortic and coronary smooth muscle cells. Atherosclerosis 164:237-43
60. Conner DA, Mathier MA, Mortensen RM, Christe M, Vatner SF, et al. 1997. β-arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to β-adrenergic stimulation. Circ. Res. 81:1021-26
61. Kohout TA, Lin FT, Perry SJ, Conner DA, Lefkowitz RJ. 2001. β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. USA 98:1601-6
62. Ahn S, Nelson CD, Garrison TR, Miller WE, Lefkowitz RJ. 2003. Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference. Proc. Natl. Acad. Sci. USA 100:1740-44
63. αs signaling in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 100:161-66
64. Ugi S, Imamura T, Ricketts W, Olefsky JM. 2002. Protein phosphatase 2A forms a molecular complex with She and regulates She tyrosine phosphorylation and downstream mitogenic signaling. Mol. Cell Biol. 22:2375-87
65. Lefkowitz RJ. 1998. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273:18677-80
66. Gao J, Li J, Ma L. 2005. Regulation of EGF-induced ERK/MAPK activation and EGFR internalization by G protein-coupled receptor kinase 2. Acta Biochim. Biophys. Sin. 37:525-31
67. Gao J, Li J, Chen Y, Ma L. 2005. Activation of tyrosine kinase of EGFR induces G βγ-dependent GRK-EGFR complex formation. FEBS Lett. 579:122-26
68. Freedman NJ, Kim LK, Murray JP, Exum ST, Brian L, et al. 2002. Phosphorylation of the platelet-derived growth factor receptor-β and epidermal growth factor receptor by G protein-coupled receptor kinase-2. Mechanisms for selectivity of desensitization. J. Biol. Chem. 277:48261-69
69. Wu JH, Goswami R, Kim LK, Miller WE, Peppel K, Freedman NJ. 2005. The platelet-derived growth factor receptor-β phosphorylates and activates G protein-coupled receptor kinase-2: a mechanism for feedback inhibition. J. Biol. Chem. 280:31027-35
70. Usui I, Imamura T, Satoh H, Huang J, Babendure JL, et al. 2004. GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J. 23:2821-29
71. Waters CM, Connell MC, Pyne S, Pyne NJ. 2005. c-Src is involved in regulating signal transmission from PDGF β receptor-GPCR(s) complexes in mammalian cells. Cell Signal. 17:263-77